解锁雌激素受体:对质母细胞瘤治疗的激素剂和对抗剂的结构洞察
Asokan Madeshwaran1, Periyasamy Vijayalakshmi2, Vidhya Rekha Umapathy3
1Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
Advances in protein chemistry and structural biology
|July 26, 2024
概括
雌激素受体 (ERs) 在质母细胞瘤 (GBM) 的进展和免疫逃避中发挥着关键作用. 准ERβ通路显示出新型GBM疗法具有较少副作用的前景.
科学领域:
- 神经瘤学神经瘤学
- 内分泌学 在内分泌学.
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有复杂病原性的侵袭性脑瘤.
- 雌激素,特别是雌激醇-17 (E2) 和它们的受体 (ERs) 影响GBM的进展,转移和血管生成.
- 在GBM病变发生过程中ERs的确切作用,包括免疫逃避和瘤微环境调节,需要进一步阐明.
研究的目的:
- 审查雌激素受体 (ER) 在质母细胞瘤 (GBM) 的参与.
- 探索ERs在GBM免疫逃避和瘤微环境调节中的机制.
- 讨论针对ER治疗GBM治疗的治疗策略.
主要方法:
- 文献综述侧重于雌激素受体和质母细胞瘤.
- 对GBM内分泌治疗的临床前发现的分析.
- 探索ERβ途径在质瘤进展中的作用.
主要成果:
- 雌激素受体与GBM免疫逃避和瘤微环境有关.
- 临床前研究表明,内分泌疗法可以改善GBM患者的生存率和生活质量.
- ERβ途径在质瘤中显示出抑制瘤的潜力,这表明副作用较少.
结论:
- 雌激素受体是GBM病变发生的关键调节体,是有前途的治疗点.
- 用激动剂向ERβ通路可能为GBM提供一种新的,耐受性良好的治疗策略.
- 生物标志物识别对于早期发现GBM和改善患者治疗结果至关重要.
更多相关视频
相关概念视频
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.7K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K


